Skip to content
10-K

Annual Report

Marker Therapeutics, Inc. MRKR

0001410578-25-000549

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 18, 2025 10.71M sh
Shares Diluted FY 2024 · Dec 31, 2023 8.81M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$16.44M
Cash And Equivalents FY 2024 · Dec 31, 2023 $15.11M
Current Liabilities FY 2024 · Dec 31, 2023 $3.07M
Total Liabilities FY 2024 · Dec 31, 2023 $3.07M
Current Assets FY 2024 · Dec 31, 2023 $17.13M
Total Assets FY 2024 · Dec 31, 2023 $17.13M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.94
Eps Basic FY 2024 · Dec 31, 2023 −$0.94
Sga Expense FY 2024 · Dec 31, 2023 $7.48M
Rd Expense FY 2024 · Dec 31, 2023 $10.42M
Net Income FY 2024 · Dec 31, 2023 −$8.24M
Operating Income FY 2024 · Dec 31, 2023 −$14.58M
Stockholders Equity FY 2024 · Dec 31, 2022 $19.6M